143 related articles for article (PubMed ID: 21126805)
1. [Sixth International Symposium on clinical applications of serum free light chain analysis, Bath, England, 23-24 September 2010].
Decaux O
Rev Med Interne; 2011 Jan; 32(1):64-6. PubMed ID: 21126805
[No Abstract] [Full Text] [Related]
2. [5th International Symposium on clinical applications of serum free light chain analysis].
Decaux O
Rev Med Interne; 2009 Jan; 30(1):96-100. PubMed ID: 19054596
[No Abstract] [Full Text] [Related]
3. Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies.
Tate JR; Graziani MS; Mollee P; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):899-905. PubMed ID: 27107838
[No Abstract] [Full Text] [Related]
4. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
Pretorius CJ
Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic accuracy of serum protein electrophoresis and free light chain measurements for monoclonal gammopathies].
Peña C; Ortiz M; Voisin J; Peralta A; Balboa V; Delgado F
Rev Med Chil; 2018 Jan; 146(1):64-67. PubMed ID: 29806679
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of free light chain measurement in monoclonal gammopathy, other haematological malignancies and autoimmune diseases].
Verebi C; Talbot A; Gendron N; Hurtado-Nedelec M
Ann Biol Clin (Paris); 2019 Aug; 77(4):397-406. PubMed ID: 31418701
[TBL] [Abstract][Full Text] [Related]
7. Reversible acute kidney injury (AKI) by active removal of serum light chains in an HIV positive patient with myeloma kidney.
Sowole L; Burns A; Kaur B; Davenport A
Clin Nephrol; 2011 Nov; 76(5):417-20. PubMed ID: 22000564
[TBL] [Abstract][Full Text] [Related]
8. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
9. Paraproteinaemia.
Frank LA; Rabin N
Br J Hosp Med (Lond); 2015 Jun; 76(6):C82-5. PubMed ID: 26053916
[No Abstract] [Full Text] [Related]
10. [Determination of light chains in serum].
Hansen CT; Nielsen L; Münster AM; Abildgaard N
Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297
[TBL] [Abstract][Full Text] [Related]
11. Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint.
Smith JD; Raines G; Schneider HG
Clin Chem Lab Med; 2016 Jun; 54(6):967-71. PubMed ID: 26677889
[TBL] [Abstract][Full Text] [Related]
12. [Update in multiple myeloma: international criteria for treatment response and renal complications].
Decaux O; Karras A
Rev Med Interne; 2009 Dec; 30(12):1080-3. PubMed ID: 19833418
[No Abstract] [Full Text] [Related]
13. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
14. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias.
Willrich MA; Katzmann JA
Clin Chem Lab Med; 2016 Jun; 54(6):907-19. PubMed ID: 26509779
[TBL] [Abstract][Full Text] [Related]
15. Management options for cast nephropathy in multiple myeloma.
Cockwell P; Hutchison CA
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
[TBL] [Abstract][Full Text] [Related]
16. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease.
Sinclair D; Wainwright L
Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400
[TBL] [Abstract][Full Text] [Related]
17. Renal improvement in myeloma with bortezomib plus plasma exchange.
Burnette BL; Leung N; Rajkumar SV
N Engl J Med; 2011 Jun; 364(24):2365-6. PubMed ID: 21675906
[No Abstract] [Full Text] [Related]
18. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
[TBL] [Abstract][Full Text] [Related]
20. The double polymethylmethacrylate filter (DELETE system) in the removal of light chains in chronic dialysis patients with multiple myeloma.
Santoro A; Grazia M; Mancini E
Blood Purif; 2013; 35 Suppl 2():5-13. PubMed ID: 23676829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
